Rajeev Dadoo

Partner at SR One Ltd.

Rajeev Dadoo

Rajeev Dadoo

Partner at SR One Ltd.

Overview
Career Highlights

Unimicro Technologies, Inc.

RelSci Relationships

886

Number of Boards

13

Relationships
RelSci Relationships are individuals Rajeev Dadoo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at True North Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Adheron Therapeutics, Inc.

Relationship likelihood: Strong

Director & Managing Partner at Action Potential Venture Capital

Relationship likelihood: Strong

Executive Director, Venture Capital at Pfizer, Inc.

Relationship likelihood: Strong

Senior Managing Director at MedImmune Ventures

Relationship likelihood: Strong

Managing Director at MPM Asset Management LLC

Relationship likelihood: Strong

Co-Founder at Concert Pharmaceuticals, Inc.

Relationship likelihood: Strong

Venture Partner at HealthCare Ventures LLC

Relationship likelihood: Strong

Managing Director at Westlake Village BioPartners

Relationship likelihood: Strong

Chairman of the Board, Co-Founder at Concert Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Rajeev Dadoo
Potential Connections via
Relationship Science
You
Rajeev Dadoo
Partner at SR One Ltd.
Education
PhD in Chemistry

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

BA in Chemistry & Mathematics

Knox College was founded in 1837 by anti-slavery social reformers, led by George Washington Gale. Many of the founders, including the Rev. Samuel Wright, actively supported the Underground Railroad. The original name for the school was Knox Manual Labor College, but it has been known by its present name since 1857. The college's name came about through a compromise among its founders. Though founded by a colony of Presbyterians and Congregationalists, the county in which the college is located was already named Knox County, after Henry Knox, the first United States Secretary of War. Arguments have been made that the college was named for Calvinist leader John Knox, but it is not certain for which Knox it was named (if not both). George Candee Gale, a great-great-grandson of two of the founders, explains that "contrary to general belief, Knox was not named for either General Knox or the Scottish Presbyterian Knox, according to my father ... Some wanted the college named for one Knox, some for the other; so they compromised on KNOX. Certainly most of them were pious enough to want the churchman and fighters enough to want the soldier as well. Knox was the site of the fifth debate between Abraham Lincoln and Stephen A. Douglas in 1858. The Old Main building is the only site from the debates that stands today. Two years after the debates, and during his presidential campaign, Lincoln was awarded the first honorary doctorate ever conferred by Knox College—a Doctor of Laws degree, announced at the commencement exercises of 5 July 1860

MBA

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

Memberships
Fellow
Current

The Society of Kauffman Fellows is a network of venture capitalists operating at 160 venture firms and corporate venture groups in 26 countries on 6 continents, collectively deploying $50B in venture capital.

Career History
Employee
Prior

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Professional
Prior

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded in 1961 and is headquartered in Waltham, MA.

Professional
Prior

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Boards & Committees
Member, Board of Directors
Current

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

Member, Board of Directors
Current

Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA.

Director
Current

True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.

Board Member
Current

BioNJ, Inc. is a private company headquartered in Trenton, NJ. The firm promotes the biotechnology industry in New Jersey. It was founded in 1994 by Abraham Abuchowski, James J. Marino and Jayne C. Gershkowitz. Debbie Hart is the current CEO of the firm.The company says this about itself: BioNJ is the life sciences trade association in New Jersey with nearly 400 Member companies representing research-based life sciences organizations and stakeholders across the ecosystem from the largest biopharmaceutical companies to early stage start-ups. BioNJ is dedicated to ensuring a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can't Wait®, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.

Transactions
Details Hidden

Bioverativ, Inc. purchases True North Therapeutics, Inc. from HBM Partners AG, Mpm Capital LLC, SR One Ltd., Kleiner Perkins Caufield & Byers LLC, OrbiMed Advisors Private Equity, Baxter Ventures

Details Hidden

Roche Holding AG purchases Adheron Therapeutics, Inc. from MedImmune Ventures, HealthCare Ventures LLC, SR One Ltd., Amgen Ventures LLC, Partners Innovation Management Co. LLC

Investments
Details Hidden

Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rajeev Dadoo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rajeev Dadoo's profile does not indicate a business or promotional relationship of any kind between RelSci and Rajeev Dadoo.